MedPath

Improving Prospective Memory Via Telehealth

Not Applicable
Completed
Conditions
Multiple Sclerosis
Registration Number
NCT05129293
Lead Sponsor
Trinity Health Of New England
Brief Summary

Up to 70% of persons with multiple sclerosis (PwMS) experience cognitive impairment, which can have a significant impact on several aspects of their daily lives. One cognitive domain that has been shown to impact daily functioning, but is understudied in MS, is prospective memory (PM). While there have been successful PM interventions in other clinical populations, to date there has not been a specific PM intervention for PwMS that has been tested in a clinical trial.

The study will be a double-masked randomized feasibility trial, with 18 participants randomized to a PM intervention and 18 participants randomized to an active control (psychoeducation). Participants will meet with an interventionist twice a week for four weeks. Feasibility will be assessed via 1) recruitment, enrollment, and retention; 2) adherence to the treatment; 3) treatment credibility and expectancy; and 4) treatment satisfaction. A preliminary effect size (Cohen's d) will be computed for the group difference using participants' performance on the Memory for Intentions Test, which will be given at baseline (week 1) and post-treatment (week 6). Participants will also complete a battery of neuropsychological measures as part of their baseline and post-treatment assessments.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Clinical diagnosis of MS
  • Able to read, write, and speak in English
  • Between the ages of 18 and 60
  • All genders
  • No history of other serious neurologic or psychiatric illness, including drug or alcohol misuse
  • No relapses within the past two months
  • Access to the Internet and a web camera
  • Not enrolled in a cognitive rehabilitation program within the past six months
  • Self-reported issues "remembering places they have to be" and "things they have to do"
Exclusion Criteria
  • No diagnosis of MS
  • Unable to complete the study protocol due to language barriers
  • Younger than 18 or older than 61
  • No gender exclusions
  • History of other serious neurologic or psychiatric illness, including drug or alcohol misuse
  • Had a relapse within the past two months
  • No access to the Internet and/or a web camera
  • Currently enrolled or enrolled in a cognitive rehabilitation program within the past six months
  • No self-reported issues with "remembering places they have to be" or "things they have to do"

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Memory for Intentions Test Total Score PercentileSix weeks

Performance on objective prospective memory (overall performance). The MIST Total Score is calculated by summing the raw scores from the six subscales, which is transformed into percentiles using age- and education-stratified normative data. Scores ranged from \<1 9 (coded as 0 for analyses) to \>99 (coded as 100 for analyses), with higher scores indicating better prospective memory performance.

Memory for Intentions Test Time Cue Subscale PercentileSix weeks

Performance on objective prospective memory (time-based)

Secondary Outcome Measures
NameTimeMethod
Perceived Deficits Questionnaire-Prospective Memory SubscaleSix weeks

Subjective prospective memory. The five items in the subscale are summed, with scores ranging between 0 and 20. Higher scores indicate more subjective prospective memory issues.

Trial Locations

Locations (1)

Mount Sinai Rehabilitation Hospital

🇺🇸

Hartford, Connecticut, United States

Mount Sinai Rehabilitation Hospital
🇺🇸Hartford, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.